With depletion of SHP2 in tumor cells, reduction of CD4+ and induction of CD8+ T cells were observed in both pulmonary tumors and spleens, and the T-cell exhaustion markers were also reduced, matching the effects of systemic SHP2 inhibition. The gene discussed is CD8A; the disease is neoplasm.